Advertisement
Advertisement

MGRX

MGRX logo

Mangoceuticals, Inc. Common Stock

0.36
USD
Sponsored
+0.01
+3.46%
Jun 24, 15:57 UTC -4
Closed
exchange

After-Market

0.34

-0.02
-4.74%

Mangoceuticals, Inc. Common Stock Profile

About

Mangoceuticals Inc. is involved in developing, marketing and selling a variety of men's health and wellness products via a secure telemedicine platform, including its uniquely formulated erectile dysfunction drug branded `Mango`. Mangoceuticals Inc. is based in DALLAS, TX.

Info & Links

CEO

Jacob D. Cohen

Headquarters

17130 DALLAS PKWY, SUITE 240
DALLAS, TX 75248, UNITED STATES

Industry

Medical Drugs

Sector

Medical

Website

www.mangoceuticals.com

Auditor

Turner, Stone & Company, L.L.P.

Share holders

40

Employees

--

Mangoceuticals, Inc. Common Stock Statistics

Valuation Measures

Market Capitalization2

5.87M

Enterprise Value

5.70M

Enterprise Value/EBITDA(ttm)

-0.41

Price to Earnings Ratio(ttm)

--

Price to Sales(ttm)

12.68

Price to Book(mrq)

0.36

Price to Cash(ytd)

--

Profitability

Gross Margin(ttm)

61.70%

Operating Margin(ttm)

-4232.31%

Profit Margin(ttm)

-4635.76%

Return on Equity(ttm)

-109.38%

Return on Invested Capital(ttm)

-114.46%

Return on Assets(ttm)

-102.40%

Income Statement

Revenue(ttm)

414.60K

Revenue Per Share(ttm)

0.02

Gross Profit(ttm)

217.30K

EBITDA(ttm)3

-13.74M

Net Income Available to Common(ttm)

-19.21M

Diluted EPS(ttm)

-2.56

Share Statistics

Beta (5Y Monthly)

2.54

52-Week Change

-80.70%

S&P 500 52-Week Change

20.78%

S&P 500 Member

Yes

Stock Optionable

Yes

Total Shares Outstanding1

17.17M

Dividend Yield

0.00%

Float4

14.25M

% Held by Insiders

16.00%

% Held by Institutions

56.72%

Balance Sheet

Total Cash(mrq)

174.60K

Total Cash Per Share(mrq)

0.01

Total Debt(mrq)

0.00

Total Debt/Equity(mrq)

0.64%

Current Ratio(mrq)

0.74%

Quick Ratio(mrq)

1.74%

Book Value Per Share(mrq)

1.13

Cash Flow

Operating Cash Flow Per Share(ytd)

-0.41

Free Cash Flow(ytd)

-4.77M

Table Key

mrq = Most Recent Quarter

ttm = Trailing Twelve Months

ytd = Year To Date

Footnotes

Data provided by Zacks Investment Research or calculated by FXEmpire. All numbers are rounded to the closest decimal.

  • 1 Total Shares outstanding is taken from the most recently filed quarterly or annual report.
  • 2 Market Cap is calculated using total shares outstanding and the most recent share price.
  • 3 EBITDA is calculated using methodology that may differ from that used by a company in its reporting.
  • 4 The float is a measure of the number of shares available for trading by the public. It's calculated by taking the number of issued and outstanding shares minus any restricted stock, which might not be publicly traded.
Advertisement